Trade MTNB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Matinas BioPharma Holdings, Inc. (MTNB) is trading at US$0.18, up 1.78% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$2.92M. Over the past 52 weeks, MTNB has traded between US$0.15 and US$2.02. On Syfe you can trade MTNB with $0 commission and add it to your watchlist.
| Previous close | US$0.17 |
|---|---|
| Market cap | US$2.92M |
| 52-week range | US$0.15 – US$2.02 |
| Volume | 196.43K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.
Year: 2014
Top Premarket Decliners
Aug 20, 11:35 AM · MT Newswires
Matinas BioPharma to Merge With GH Power; Signs Deal to Sell Subsidiary, Lead Product Candidate
Jul 13, 1:03 PM · MT Newswires
Matinas BioPharma Files $150 Million Mixed Shelf Registration
Jun 16, 8:29 PM · MT Newswires
Matinas BioPharma Holdings, Inc. (MTNB) stock is trading at US$0.18, +1.78% from the previous close of US$0.17.
The market cap for Matinas BioPharma Holdings, Inc. (MTNB) stock is approximately US$2.92M.
The 52-week high for Matinas BioPharma Holdings, Inc. (MTNB) stock is US$2.02.
The 52-week low for Matinas BioPharma Holdings, Inc. (MTNB) stock is US$0.15.
Matinas BioPharma Holdings, Inc. (MTNB) does not currently pay a dividend.
Stay on top of MTNB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
